Business Standard

Sunday, January 12, 2025 | 05:25 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Eugia Pharma Specialities receives USFDA warning for Unit III

Image

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugia Pharma Specialities, a subsidiary of the company. There is no impact on the existing supplies to the US market.

The warning letter comes subsequent to receiving the Official Action Indicated (OAI) status from USFDA earlier in May 2024.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 16 2024 | 10:06 AM IST

Explore News